Most studies of clinical drug resistance to nucleoside and nonnucleoside reverse transcriptase (RT) inhibitors (NRTIs and NNRTIs, respectively) analyze the first 300 amino acids of RT and do not include the C-terminal connection subdomain (CN) or the RNase H domain (RH). We observed that several mutations in the CN and RH reduce RNase H activity, thereby affecting the balance between RNA degradation and nucleotide excision, and enhancing NRTI resistance. Our recent studies have demonstrated that mutations in the CN and the RH can also increase resistance to NNRTIs, and suggest a parallel mechanism by which resistance to both classes of RT inhibitors can be increased. It has been observed that CN mutations are present in drug-naive patients, and we are exploring the mechanisms by which CN mutations may be selected prior to initiation of antiviral therapy.While investigating the functional relevance of A3G localization to P bodies, we found that P body-associated protein Mov10 potently inhibits HIV-1 replication by reducing virus production and inhibiting reverse transcription. We are elucidating the mechanisms by which Mov10 inhibits HIV-1 particle production and reverse transcription. While examining the effects of A3G and A3F on viral DNA integration, we observed that uracil DNA glycosylase activity in the target cells, not the virus producer cells, results in nicking of the minus-strand DNA. We will explore the significance of this unexpected phenotype to viral replication.[Corresponds to Pathak Project 3 in the October 2011 site visit report of the HIV Drug Resistance Program]
| Liu, Yang; Nikolaitchik, Olga A; Rahman, Sheikh Abdul et al. (2017) HIV-1 Sequence Necessary and Sufficient to Package Non-viral RNAs into HIV-1 Particles. J Mol Biol 429:2542-2555 |
| Nikolaitchik, Olga; Keele, Brandon; Gorelick, Robert et al. (2015) High recombination potential of subtype A HIV-1. Virology 484:334-40 |
| Delviks-Frankenberry, Krista; Paprotka, Tobias; Cingöz, Oya et al. (2013) Generation of multiple replication-competent retroviruses through recombination between PreXMRV-1 and PreXMRV-2. J Virol 87:11525-37 |
| Delviks-Frankenberry, Krista A; Lengruber, Renan B; Santos, Andre F et al. (2013) Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistance. Virology 435:433-41 |
| Hatch, Steven C; Sardo, Luca; Chen, Jianbo et al. (2013) Gag-dependent enrichment of HIV-1 RNA near the uropod membrane of polarized T cells. J Virol 87:11912-5 |
| Murgai, Meera; Thomas, James; Cherepanova, Olga et al. (2013) Xenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels. Retrovirology 10:34 |
| Nikolaitchik, Olga A; Dilley, Kari A; Fu, William et al. (2013) Dimeric RNA recognition regulates HIV-1 genome packaging. PLoS Pathog 9:e1003249 |
| Del Prete, Gregory Q; Kearney, Mary F; Spindler, Jon et al. (2012) Restricted replication of xenotropic murine leukemia virus-related virus in pigtailed macaques. J Virol 86:3152-66 |
| Delviks-Frankenberry, Krista; Cingöz, Oya; Coffin, John M et al. (2012) Recombinant origin, contamination, and de-discovery of XMRV. Curr Opin Virol 2:499-507 |
| Cingöz, Oya; Paprotka, Tobias; Delviks-Frankenberry, Krista A et al. (2012) Characterization, mapping, and distribution of the two XMRV parental proviruses. J Virol 86:328-38 |
Showing the most recent 10 out of 12 publications
